| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.42 | 4e-20 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.28 | 2e-09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.22 | 4e-07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |